GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (FRA:K5F) » Definitions » Gross Profit

Genenta Science SPA (FRA:K5F) Gross Profit : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Gross Profit?

Genenta Science SPA's gross profit for the six months ended in Jun. 2024 was €0.00 Mil. Genenta Science SPA's gross profit for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Genenta Science SPA's gross profit for the six months ended in Jun. 2024 was €0.00 Mil. Genenta Science SPA's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Therefore, Genenta Science SPA's Gross Margin % for the quarter that ended in Jun. 2024 was N/A%.

Genenta Science SPA had a gross margin of N/A% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage


Genenta Science SPA Gross Profit Historical Data

The historical data trend for Genenta Science SPA's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA Gross Profit Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
- - - - -

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Genenta Science SPA's Gross Profit

For the Biotechnology subindustry, Genenta Science SPA's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genenta Science SPA's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's Gross Profit distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's Gross Profit falls into.



Genenta Science SPA Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Genenta Science SPA's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Genenta Science SPA's Gross Profit for the quarter that ended in Jun. 2024 is calculated as

Gross Profit (Q: Jun. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Genenta Science SPA's Gross Margin % for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Genenta Science SPA  (FRA:K5F) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Genenta Science SPA had a gross margin of N/A% for the quarter that ended in Jun. 2024 => No sustainable competitive advantage


Genenta Science SPA Gross Profit Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Genenta Science SPA Business Description

Traded in Other Exchanges
Address
Via Olgettina No. 58, Milan, ITA, 20132
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

Genenta Science SPA Headlines

No Headlines